Athanor Capital’s ResMed RMD Stock Holding History

Athanor Capital’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-4,359	Closed	-$747K	–	806
2020 Q3	$747K	Buy	+4,359	New	+$805K	0.03%	276

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Athanor Capital's RMD Position: Q4 2020 in Review

Athanor Capital sold out of ResMed (RMD) in Q4 2020, closing a stake of 4,359 shares — an estimated $747K sold.

Athanor Capital first reported a position in RMD in Q3 2020 and held it in 1 quarter. The position peaked at $747K in Q3 2020. 663 funds tracked by Wall St. Rank hold RMD as of Q4 2020.

Athanor Capital reported no remaining ResMed position as of Q4 2020 after selling out during the quarter.
Athanor Capital sold 4,359 ResMed shares in Q4 2020, an estimated $747K.
Athanor Capital first reported a position in ResMed in Q3 2020 and held it in 1 quarter.
Athanor Capital's ResMed position peaked at $747K in Q3 2020.
663 funds tracked by Wall St. Rank held ResMed as of Q4 2020.

Based on Athanor Capital's 13F filing for Q4 2020, filed 16 Feb 2021.